New funding to advance non-surgical brain interface technology and expand clinical and engineering capabilities globally
Gates Frontier, Bezos Expeditions, Reliance Digital Health Limited, Greenoaks, Alumni Ventures, Moore Strategic Ventures, and Project X join ARCH as new additional investors
BioAsia 2026 represents a decisive shift toward execution, scale, and global competitiveness, reflecting the rapid evolution of the life sciences ecosystem
The device delivers clear, high-quality images to support accurate diagnoses across a broad range of patient groups
Acquisition expands Novo Nordisk’s leadership in obesity-related comorbidities and metabolic diseases
Transform healthcare by integrating expertise from AI, clinical sciences, and basic sciences to harness India’s extensive data sets for improving the access to healthcare
The Central government’s decision to exempt three more cancer medicines from customs duty is a commendable step towards making cancer drugs more affordable
Abbott's first-of-its-kind i2i technology enables synchronized communication between two leadless pacemakers
Survodutide has potential to become best-in-class treatment for metabolic dysfunction-associated steatohepatitis
The company will be managing orders and warehouse operations for Little's, Lacto-calamine, Tri-activ, I-feel, Ourdaily, and Sloan's through the Unicommerce platform
Subscribe To Our Newsletter & Stay Updated
